| Title | A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic HPV Associated Head and Neck Squamous Cancer |
|---|---|
| Disease/Condition | Head and Neck Cancer,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Human Papilloma Virus (HPV),Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Balazs Halmos, MD |
| Contact Name | Balazs Halmos, MD |
| Contact Email | bahalmos@montefiore.org |
| Protocol Number | 17-11-27-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | HPV-Associated Head and Neck Cancer |
| Adult, Pediatric, Both | Adult |